Siemens Healthineers AG (OTCMKTS:SMMNY) Sees Large Drop in Short Interest

Siemens Healthineers AG (OTCMKTS:SMMNY) was the target of a large drop in short interest in June. As of June 30th, there was short interest totaling 51,538 shares, a drop of 55.6% from the June 15th total of 116,151 shares. Based on an average daily volume of 345,299 shares, the days-to-cover ratio is currently 0.1 days.

Analyst Ratings Changes

Separately, Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

Siemens Healthineers Stock Performance

Shares of SMMNY opened at $19.82 on Thursday. Siemens Healthineers has a twelve month low of $19.32 and a twelve month high of $28.92. The firm’s 50-day moving average is $19.84 and its two-hundred day moving average is $22.31.

Siemens Healthineers (OTCMKTS:SMMNY) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.29 by $0.02. The business had revenue of $6.68 billion during the quarter, compared to analysts’ expectations of $6.96 billion.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.